These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 20446043)

  • 1. SERMs and SERMs with estrogen for postmenopausal osteoporosis.
    Bolognese MA
    Rev Endocr Metab Disord; 2010 Dec; 11(4):253-9. PubMed ID: 20446043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current and emerging pharmacologic therapies for the management of postmenopausal osteoporosis.
    Lewiecki EM
    J Womens Health (Larchmt); 2009 Oct; 18(10):1615-26. PubMed ID: 19857095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of postmenopausal osteoporosis and the prevention of fractures.
    Gambacciani M; Levancini M
    Panminerva Med; 2014 Jun; 56(2):115-31. PubMed ID: 24942322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Selective estrogen receptor modulators in treatment of postmenopausal osteoporosis].
    Meczekalski B; Czyzyk A
    Ginekol Pol; 2009 Mar; 80(3):213-7. PubMed ID: 19382614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of SERMs for treatment in postmenopausal women.
    Pinkerton JV; Thomas S
    J Steroid Biochem Mol Biol; 2014 Jul; 142():142-54. PubMed ID: 24373794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The discovery and development of selective estrogen receptor modulators (SERMs) for clinical practice.
    Maximov PY; Lee TM; Jordan VC
    Curr Clin Pharmacol; 2013 May; 8(2):135-55. PubMed ID: 23062036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective estrogen modulators in menopause.
    Gambacciani M
    Minerva Ginecol; 2013 Dec; 65(6):621-30. PubMed ID: 24346250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hormone replacement and selective estrogen receptor modulators (SERMS) in the prevention and treatment of postmenopausal osteoporosis].
    Pfeilschifter J
    Orthopade; 2001 Jul; 30(7):462-72. PubMed ID: 11515185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New management options for osteoporosis with emphasis on SERMs.
    McClung MR
    Climacteric; 2015; 18 Suppl 2():56-61. PubMed ID: 26503459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of bazedoxifene, a novel selective estrogen receptor modulator for the prevention and treatment of postmenopausal osteoporosis.
    Palacios S
    Curr Med Res Opin; 2010 Jul; 26(7):1553-63. PubMed ID: 20429824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective estrogen receptor modulators for postmenopausal osteoporosis: current state of development.
    Gennari L; Merlotti D; Valleggi F; Martini G; Nuti R
    Drugs Aging; 2007; 24(5):361-79. PubMed ID: 17503894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue selective estrogen complex (TSEC): a review.
    Pickar JH; Boucher M; Morgenstern D
    Menopause; 2018 Sep; 25(9):1033-1045. PubMed ID: 29533367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lasofoxifene: a new type of selective estrogen receptor modulator for the treatment of osteoporosis.
    Gennari L
    Drugs Today (Barc); 2006 Jun; 42(6):355-67. PubMed ID: 16845439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Selective estrogen receptor modulators (SERMs)].
    Chaki O
    Nihon Rinsho; 2015 Oct; 73(10):1673-81. PubMed ID: 26529929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profile of bazedoxifene/conjugated estrogens for the treatment of estrogen deficiency symptoms and osteoporosis in women at risk of fracture.
    Rossini M; Lello S; Sblendorio I; Viapiana O; Fracassi E; Adami S; Gatti D
    Drug Des Devel Ther; 2013; 7():601-10. PubMed ID: 23901263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SERMs in the prevention and treatment of postmenopausal osteoporosis: an update.
    Kulak Júnior J; Kulak CA; Taylor HS
    Arq Bras Endocrinol Metabol; 2010 Mar; 54(2):200-5. PubMed ID: 20485909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of osteoporosis and reduction in risk of invasive breast cancer in postmenopausal women with raloxifene.
    Ko SS; Jordan VC
    Expert Opin Pharmacother; 2011 Mar; 12(4):657-74. PubMed ID: 21294695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue-selective estrogen complexes for postmenopausal women.
    Mirkin S; Komm BS
    Maturitas; 2013 Nov; 76(3):213-20. PubMed ID: 23849704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective estrogen receptor modulators: A possible new treatment of osteoporosis in males.
    Kastelan D; Giljevic Z; Kraljevic I; Korsic M
    Med Hypotheses; 2006; 67(5):1052-3. PubMed ID: 16790322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective estrogen receptor modulator (SERM) for the treatment of osteoporosis in postmenopausal women: focus on lasofoxifene.
    Gennari L; Merlotti D; Nuti R
    Clin Interv Aging; 2010 Feb; 5():19-29. PubMed ID: 20169039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.